Magnesium sulphate injection administration

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have all the information needed for a comprehensive answer. Here it is:

Magnesium Sulphate (MgSO4) Injection - Administration

Preparation & Available Formulation

  • Available as: 500 mg/mL (50% solution) for injection
  • Before administration, always dilute the 50% solution - concentrated MgSO4 must NOT be given as a direct rapid IV push undiluted (except in cardiac arrest situations where speed is critical)

Indications

IndicationNotes
Eclampsia / Seizure treatmentFirst-line anticonvulsant
Preeclampsia with severe featuresSeizure prophylaxis (intrapartum + ≥24 hrs postpartum)
Torsades de pointes / polymorphic VTAntiarrhythmic (inhibits calcium currents)
Fetal neuroprotectionGiven before delivery <32 weeks' gestation
HypomagnesaemiaReplacement therapy

Standard Dosing Protocols

1. Eclampsia / Severe Preeclampsia (IV Route - Preferred)

Loading Dose:
  • 4-6 g IV diluted in 100 mL normal saline or 5% dextrose
  • Infused over 15-30 minutes
Maintenance Dose:
  • 1-2 g/hour as a continuous IV infusion
  • Continue for at least 24 hours after the last seizure or delivery
In renal insufficiency (creatinine >1 mg/dL): reduce bolus to 2 g IV, then obtain serum magnesium level before increasing infusion rate - Tintinalli's Emergency Medicine

2. Intramuscular Route (Pritchard Regimen - resource-limited settings)

  • Loading: 4 g IV slow push (over 3-5 min) + 10 g IM (5 g into each buttock as 50% solution with 1 mL of 2% lignocaine to reduce pain)
  • Maintenance: 5 g IM every 4 hours into alternating buttocks
  • IM injections are painful and can cause tissue injury; IV preferred when available

3. Torsades de Pointes / Cardiac Arrhythmia (IV Route)

  • 1-2 g IV diluted in normal saline or 5% dextrose
  • Given as a rapid bolus in patients with a pulse
  • Note: Rapid IV administration can cause vasodilation, flushing, and hypotension - Tintinalli's Emergency Medicine

4. Fetal Neuroprotection (Preterm <32 weeks)

  • 4 g IV loading dose followed by a maintenance infusion
  • Used when delivery is imminent <32 weeks to reduce risk of cerebral palsy - Creasy & Resnik's Maternal-Fetal Medicine

Serum Magnesium Levels and Clinical Effects

EffectSerum Level (mEq/L)
Therapeutic anticonvulsant range4.8 - 8.4
Loss of deep tendon reflexes (DTR)7 - 10
Respiratory paralysis10 - 13
ECG changes>15
Cardiac arrest>25
Presence of deep tendon reflexes = serum magnesium is NOT dangerously high. Loss of DTR = first clinical warning sign of toxicity. - Creasy & Resnik's Maternal-Fetal Medicine

Monitoring During Infusion

Monitor at least every 2 hours:
  1. Deep tendon reflexes (patellar reflex) - loss = stop infusion
  2. Respiratory rate - must be ≥12-16/min; respiratory depression occurs at ~12 mg/dL
  3. Urine output - must be ≥25-30 mL/hour (MgSO4 is renally excreted; half-life ~4 hours in normal renal function, prolonged in renal impairment)
  4. Serum magnesium levels (where available)
Stop infusion immediately if:
  • Loss of patellar reflexes
  • Respiratory rate <12/min
  • Urine output <25 mL/hour

Management of Toxicity / Hypermagnesaemia

AntidoteDoseNotes
Calcium gluconate 10%1 g IV slowly (over 3-5 min)Directly reverses respiratory and cardiac toxicity
Oxygen + ventilatory supportAs neededFor respiratory depression
Keep calcium gluconate at the bedside throughout the infusion.

Special Populations

  • Renal impairment: Reduce maintenance infusion rate; monitor serum levels closely (excretion depends on GFR and tubular transport maximum)
  • Oliguric patients: Use with extreme caution; consider reducing dose to 0.5 g/hour with frequent monitoring
  • Neonate: Neonatal hypermagnesaemia possible if mother is on MgSO4 near delivery - monitor baby for respiratory depression, hypotonia, and poor suck

Drug Interaction Note

Magnesium potentiates neuromuscular blocking agents (e.g., vecuronium, rocuronium) and may enhance the effects of calcium channel blockers (e.g., nifedipine) - the combination is generally safe in obstetrics but be aware of additive hypotensive effects.

Sources: Creasy & Resnik's Maternal-Fetal Medicine, 9e | Rosen's Emergency Medicine | Tintinalli's Emergency Medicine
This is a shared conversation. Sign in to Orris to start your own chat.